Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

U.S. patent issues for GenVec's advanced gene therapy vectors

April 3, 1998

TAPET efficacy reported at AACR meeting

April 2, 1998

Novel liposomal delivery system available for licensing from NCI/NIH

April 2, 1998

NIH offers gene expression detection technology for licensing

March 30, 1998

Demeter granted U.S. patent for peptide stabilization

March 30, 1998

PIN*POINT method available for licensing from NIH

March 27, 1998

Incyte licenses RNA amplification technology and related patent

March 27, 1998

FDA advisory committee recommends expanded labeling for CEPRATE SC System

March 26, 1998

Ribozyme, Parke-Davis collaboration confirmed

March 25, 1998

Progenitor, CAT establish gene-to-clinic collaboration

March 25, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...